Keylika
Private Company
Revolutionizing treatment for Iron Deficiency Anemia.
Biotechnology
Walnut Creek, CA
2-10 employees
Founded 2022
About Keylika
Keylika is a pharmaceutical company that uses AI-enabled drug design and nanotechnology to develop novel drug delivery systems for breakthrough therapies. Its flagship products are prescription transdermal and buccal patches designed to treat iron deficiency anemia (IDA) by delivering a proprietary iron complex directly into the bloodstream. This approach aims to provide an effective, side-effect-free alternative to traditional oral and IV iron therapies, primarily for women and children.
Company Classification
Customer Types
B2BB2B2C
Business Models
Products
Product & Service Types
Transdermal drug delivery systemsPrescription iron deficiency therapiesDermocosmetic products
Funding
No. of Funding Rounds
1
Customers
| Customer | Success Story | Source |
|---|---|---|
| Dr. Christy Evans implemented Keylika's buccal patch in her practice to treat patients suffering from iron deficiency anemia. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos